BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36942402)

  • 1. Managing the burden of incidental FDG-avid thyroid nodules: New consensus statement.
    Perros P
    Clin Endocrinol (Oxf); 2024 May; 100(5):486-487. PubMed ID: 36942402
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
    Sharma SD; Jacques T; Smith S; Watters G
    J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
    Yerubandi V; Chin BB; Sosa JA; Hoang JK
    AJR Am J Roentgenol; 2016 Feb; 206(2):420-5. PubMed ID: 26797373
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
    J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrasound stratification of the FDG-avid thyroid nodule.
    Beech P; Lavender I; Jong I; Soo G; Ramdave S; Chong A; Nandurkar D
    Clin Radiol; 2016 Feb; 71(2):164-9. PubMed ID: 26683088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-Aided Diagnostic Technique in 2-Deoxy-2-[
    Lin YH; Tsai YC; Lin KJ; Der Lin J; Wang CC; Chen ST
    Ultrasound Med Biol; 2019 Jan; 45(1):108-121. PubMed ID: 30336966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.
    Kao YH; Lim SS; Ong SC; Padhy AK
    Can Assoc Radiol J; 2012 Nov; 63(4):289-93. PubMed ID: 22136969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidentally detected 18 F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
    Owens C; Fitzhugh A; Harrington K; Paleri V; Sharma B; Shur J; Ap Dafydd D
    Nucl Med Commun; 2023 Sep; 44(9):810-815. PubMed ID: 37272278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography-positive thyroid nodules: rate of malignancy and histological features.
    Flukes S; Lenzo N; Moschilla G; Sader C
    ANZ J Surg; 2016 Jun; 86(6):487-91. PubMed ID: 25169781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.
    Lang BH; Law TT
    Oncologist; 2011; 16(4):458-66. PubMed ID: 21378078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with fluorine-18-fluorodeoxyglucose uptake in benign thyroid nodules.
    Ohba K; Sasaki S; Oki Y; Nishizawa S; Matsushita A; Yoshino A; Suda T; Nakamura H
    Endocr J; 2013; 60(8):985-90. PubMed ID: 23707998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
    Sebastianes FM; Cerci JJ; Soares Júnior J; Zanoni PH; Tomimori EK; Camargo RY; Meneghetti JC; Pereira MA
    Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1176-83. PubMed ID: 19082307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hürthle cell neoplasms: a new differential diagnosis for 18F-FDOPA-avid thyroid nodules?
    Pauleau G; Palazzo FF; Essamet W; Sebag F; Taïeb D
    J Clin Endocrinol Metab; 2013 Mar; 98(3):865-6. PubMed ID: 23337720
    [No Abstract]   [Full Text] [Related]  

  • 15. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.
    Bonabi S; Schmidt F; Broglie MA; Haile SR; Stoeckli SJ
    Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2555-60. PubMed ID: 22298251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma concurrently diagnosed with a diffuse large B-cell lymphoma localized in the neck.
    Puget G; Trampal C; Calvo N; Carrera MJ; Conangla M; Sitges-Serra A; Besses C; Salar A
    Leuk Lymphoma; 2007 Feb; 48(2):425-7. PubMed ID: 17325910
    [No Abstract]   [Full Text] [Related]  

  • 18. Review. 18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.
    Al-Nahhas A; Khan S; Gogbashian A; Banti E; Rampin L; Rubello D
    In Vivo; 2008; 22(1):109-14. PubMed ID: 18396792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of non
    Sheldon JA; Yap KK; Taubman KL; Schlicht SM
    J Med Imaging Radiat Oncol; 2018 Apr; 62(2):194-202. PubMed ID: 29230956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Incidentalomas Detected on
    Chung SR; Choi YJ; Suh CH; Kim HJ; Lee JJ; Kim WG; Sung TY; Lee YM; Song DE; Lee JH; Baek JH
    Thyroid; 2018 Jun; 28(6):762-768. PubMed ID: 29759033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.